Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1007 participants.
Also called NCT04863664
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,007 participants
- Registry
-
NCT04863664
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Hong Kong SAR China, Italy, Japan, Malaysia, Netherlands, Poland, Portugal, Serbia, Singapore, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04863664. Non-randomized; no masking; primary purpose treatment. Start 2021-06-21 (actual); primary completion 2025-09-03 (actual). Results posted on 2026-11-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
- Condition
- Ventricular Tachyarrhythmia
- Intervention (Device)
- Defibrillation (RV Implant)
- Intervention (Device)
- Defibrillation (LBBAP Implant)
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct04863664- Content hash
d19e7a5debe79e85301e7f5d0be5aa780192d5338007c65053f97fa6b52bdb4a